The clinical use of IDH1 and IDH2 mutations in gliomas-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The clinical use of IDH1 and IDH2 mutations in gliomas

Published:2018-11-29 Issue:12 Volume:18 Page:1041-1051
ISSN:1473-7159
Container-title:Expert Review of Molecular Diagnostics
language:en
Short-container-title:Expert Review of Molecular Diagnostics

Author:

Picca Alberto¹,Berzero Giulia²³,Di Stefano Anna Luisa⁴⁵,Sanson Marc⁴⁶

Affiliation:

1. Neuroscience Consortium, University of Pavia, Pavia, Italy

2. Neuroncology Unit, IRCCS Mondino Foundation, Pavia, Italy

3. Biomedical Sciences, University of Pavia, Pavia, Italy

4. Sorbonne Universités, Paris, France

5. Department of Neurology, Foch Hospital, Suresnes, Paris, France

6. Service de Neurologie 2, AP-HP, Hôpital de la Pitié-Salpêtrière, Paris, France

Funder

INCa-DGOS-Inserm_12560

Publisher

Informa UK Limited

Subject

Genetics,Molecular Biology,Molecular Medicine,Pathology and Forensic Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737159.2018.1548935

Reference157 articles.

1. An Integrated Genomic Analysis of Human Glioblastoma Multiforme

2. IDH1andIDH2Mutations in Gliomas

3. Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

4. Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping

5. IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of IDH and EGFR as biomarkers in glioblastoma multiforme: A case-control study;Heliyon;2024-08

2. IDH1 mutation is detectable in plasma cell-free DNA and is associated with survival outcome in glioma patients;BMC Cancer;2024-01-03

3. Current and Future Drugs for Brain Tumors Treatment;Advanced Imaging and Therapy in Neuro-Oncology;2024

4. Advances in molecular and imaging biomarkers in lower-grade gliomas;Expert Review of Neurotherapeutics;2023-11-20

5. Vascular differences between IDH‐wildtype glioblastoma and astrocytoma IDH‐mutant grade 4 at imaging and transcriptomic levels;NMR in Biomedicine;2023-07-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3